Quadrant Capital Group’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.52M Buy
27,794
+713
+3% +$212K 0.22% 59
2025
Q4
$8.94M Sell
27,081
-724
-3% -$245K 0.27% 45
2025
Q3
$9.6M Buy
27,805
+12,715
+84% +$3.85M 0.31% 39
2025
Q2
$4.71M Sell
15,090
-5,567
-27% -$2.13M 0.17% 86
2025
Q1
$10.8M Buy
20,657
+9,410
+84% +$4.81M 0.4% 29
2024
Q4
$5.69M Sell
11,247
-225
-2% -$128K 0.39% 33
2024
Q3
$6.71M Sell
11,472
-37
-0.3% -$20.9K 0.47% 30
2024
Q2
$5.86M Buy
11,509
+509
+5% +$249K 0.44% 29
2024
Q1
$5.44M Sell
11,000
-1,028
-9% -$523K 0.43% 32
2023
Q4
$6.33M Buy
12,028
+854
+8% +$455K 0.54% 26
2023
Q3
$5.63M Buy
11,174
+135
+1% +$66.4K 0.56% 28
2023
Q2
$5.31M Sell
11,039
-88
-0.8% -$43K 0.53% 26
2023
Q1
$5.26M Buy
11,127
+477
+4% +$230K 0.55% 26
2022
Q4
$5.65M Buy
10,650
+579
+6% +$307K 0.64% 24
2022
Q3
$5.09M Buy
10,071
+702
+7% +$369K 0.67% 23
2022
Q2
$4.81M Buy
9,369
+386
+4% +$194K 0.65% 26
2022
Q1
$4.58M Buy
8,983
+86
+1% +$41.5K 0.55% 29
2021
Q4
$4.47M Buy
8,897
+503
+6% +$228K 0.53% 33
2021
Q3
$3.28M Buy
8,394
+441
+6% +$183K 0.46% 39
2021
Q2
$3.19M Buy
7,953
+349
+5% +$139K 0.46% 38
2021
Q1
$2.83M Buy
7,604
+1,538
+25% +$533K 0.46% 36
2020
Q4
$2.13M Buy
6,066
+269
+5% +$90.2K 0.4% 39
2020
Q3
$1.81M Sell
5,797
-730
-11% -$224K 0.39% 40
2020
Q2
$1.93M Sell
6,527
-180
-3% -$51.6K 0.43% 43
2020
Q1
$1.67M Sell
6,707
-186
-3% -$51.2K 0.28% 66
2019
Q4
$1.99M Buy
6,893
+2,331
+51% +$610K 0.24% 65
2019
Q3
$978K Sell
4,562
-1,943
-30% -$469K 0.15% 114
2019
Q2
$1.57M Buy
6,505
+383
+6% +$92.1K 0.25% 73
2019
Q1
$1.49M Buy
6,122
+1,707
+39% +$435K 0.26% 63
2018
Q4
$1.08M Buy
4,415
+113
+3% +$29.9K 0.29% 62
2018
Q3
$1.12M Buy
4,302
+35
+0.8% +$9.1K 0.32% 55
2018
Q2
$1.02M Buy
4,267
+130
+3% +$31.2K 0.36% 60
2018
Q1
$864K Buy
4,137
+178
+4% +$40.7K 0.31% 63
2017
Q4
$863K Buy
3,959
+182
+5% +$38.6K 0.34% 61
2017
Q3
$723K Sell
3,777
-173
-4% -$33.4K 0.3% 69
2017
Q2
$687K Sell
3,950
-294
-7% -$51.6K 0.3% 67
2017
Q1
$684K Buy
4,244
+180
+4% +$29.5K 0.3% 68
2016
Q4
$641K Buy
4,064
+56
+1% +$8.37K 0.32% 61
2016
Q3
$552K Sell
4,008
-90
-2% -$12.6K 0.36% 51
2016
Q2
$571K Buy
4,098
+303
+8% +$40.4K 0.39% 48
2016
Q1
$481K Buy
3,795
+320
+9% +$37.9K 0.31% 58
2015
Q4
$401K Sell
3,475
-22
-0.6% -$2.57K 0.28% 75
2015
Q3
$402K Buy
3,497
+11
+0.3% +$1.32K 0.28% 69
2015
Q2
$420K Buy
+3,486
New +$412K 0.27% 71

Other funds holding UNH

Quadrant Capital Group's UNH Position: Q1 2026 in Review

Quadrant Capital Group increased its UnitedHealth (UNH) stake by 2.6% in Q1 2026, buying an estimated $212K and bringing the position to 27,794 shares worth $7.52M. The position accounts for 0.22% of the portfolio, ranked #59.

Quadrant Capital Group first reported a position in UNH in Q2 2015 and has held it in 44 quarters since. The position peaked at $10.8M in Q1 2025. 3,020 funds tracked by Wall St. Rank hold UNH as of Q1 2026.

  • Quadrant Capital Group held 27,794 shares of UnitedHealth worth $7.52M as of Q1 2026.
  • Quadrant Capital Group bought 713 UnitedHealth shares in Q1 2026, an estimated $212K.
  • UnitedHealth made up 0.22% of Quadrant Capital Group's portfolio in Q1 2026, its #59 holding.
  • Quadrant Capital Group first reported a position in UnitedHealth in Q2 2015 and has held it in 44 quarters since.
  • Quadrant Capital Group's UnitedHealth position peaked at $10.8M in Q1 2025.
  • 3,020 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.

Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.